期刊文献+

人红细胞膜CD59的分离及对依赖补体血小板损伤的保护 被引量:8

Fractionation of CD59 from human erythrocyte membrane and protection on complement dependent platelet injury
下载PDF
导出
摘要 目的研究补体调节蛋白CD59通过阻止补体攻膜复合物(MAC)的形成发挥其对依赖补体血小板损伤的保护作用。方法用连续柱层析从眼镜蛇粗毒中分离纯化出眼镜蛇毒因子(CVF)。人红细胞膜经低渗破膜、超滤、木瓜蛋白酶消化、正丁醇抽提和连续柱层析分离纯化出补体调节蛋白CD59。用ChronoLog型血小板聚集仪测定血小板变形、聚集和ATP释放反应。结果预先加入CD59可抑制CVF引起的大白鼠血小板变形和ATP释放,不影响CVF引起的血小板聚集及粘附性增加。结论血小板膜表面形成的MAC是补体激活引起血小板变形和ATP释放的关键。 AIM To study the protective action of complement regulatory protein CD59 on complement dependent platelet injury by preventing the formation of membrane attack complex (MAC). METHODS Cobra venom factor (CVF) was separated and purified by successive chromatography from crude cobra venom. CD59 was fractionated and purified by low osmosis preparation, ultrafiltration, papain digestion, n butanol abstrct and successive chromatography from the membrane of human erythrocytes. Platelet shape change, aggregation and ATP release were detected by Chrono Log platelet aggregation instrument. RESULTS CD59 with inhibition of the formation of MAC on the cellular membrane can prevent platelet shape change and ATP release induced by CVF but unaffect platelet aggregation and adhesiveness. CONCLUSION MAC plays an important part in platelet shape change and ATP release induced by activation of complements. CD59 has protective action on complement dependent platelet injury.
出处 《中国药理学通报》 CAS CSCD 北大核心 1998年第6期512-515,共4页 Chinese Pharmacological Bulletin
基金 国家自然科学基金
关键词 红细胞膜 CD59 分离 血小板损伤 眼镜蛇毒因子 CD59 platelet membrane attack complex cobra venom factor
  • 相关文献

同被引文献20

  • 1Dong XU,Shou-jian HUANG,Jin-qun WANG,Chu-kun WU.Protective effect of membrane cofactor protein against complementdependent injury[J].Acta Pharmacologica Sinica,2005,26(8):987-991. 被引量:2
  • 2陆锋,张梅,郭力.缺血性脑血管疾病患者血小板膜糖蛋白变化及临床意义[J].中国实用内科杂志,2006,26(6):817-819. 被引量:5
  • 3邵良,季美华,陶国华,谢玮,丁莉,张丽华,朱震勤,姚鸿莉.进展性卒中患者血小板膜糖蛋白CD41和CD61及CD62P的表达[J].中国脑血管病杂志,2007,4(4):156-159. 被引量:4
  • 4钟学礼.糖类肾上腺皮质激素在内科临床的应用[J].上海医学,1983,9:57-57.
  • 5[3]Wojda U,Njoroge J,Miller J.Protection of cells from complement-mediated attack:CD59 receptor clustering for the entry of macromolecules into hematopoietic cells.Immunological Investigations,1999,28:127-135.
  • 6[8]Morgan BP.Isolation and characterization of the complement-inhibiting protein CD59 antigen from platelet membranes.Bioehem J,1992,3:409-413.
  • 7Jiang H, Wagner E, Zhang H, et al. Complement I inhibitor is a regulator of the alternative complement pathway[J]. J Exp Med, 2001,194(11): 1609- 1616.
  • 8Fu Q, Mcphie P, Gowda DC. Methionine modification impairs the C5- cleavage function of cobra venom factor- dependent C3/C5 convertase[J]. Biochem Mol Biol Int, 1998,45( 1):133- 144.
  • 9Xu Y, Ma M, Ippolito C,C, et al. Complement activation in factor D - deficient mice[J]. Proc Natl Acad Sci USA, 2001,98(25) : 14577 - 14582.
  • 10Rinder CS, Rinder HM, Smith BR, et al. Blockade of C5a and C5b - 9 generation inhibits leukocyte and platelet activation during extracorporeal circulation[J]. J clin Invest, 1995,96(3) : 1564 - 1572.

引证文献8

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部